La Jolla, CA, United States of America

David Sai-Ho Chu

USPTO Granted Patents = 21 

Average Co-Inventor Count = 8.3

ph-index = 7

Forward Citations = 204(Granted Patents)


Location History:

  • San Diego, CA (US) (2021 - 2022)
  • La Jolla, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations and Contributions of David Sai-Ho Chu in Biotechnology

Introduction

David Sai-Ho Chu, a prominent inventor based in La Jolla, California, has made significant contributions to the field of biotechnology, holding a remarkable total of 21 patents. His work primarily focuses on nucleic acid-polypeptide compositions, which have crucial implications for cancer treatment and pharmaceutical development.

Latest Patents

Among his latest innovations, David has developed a patent titled "Nucleic acid-polypeptide compositions and uses thereof." This patent outlines compositions and pharmaceutical formulations that consist of a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Furthermore, the patent describes methods for treating cancer using these innovative compositions and formulations, signifying an important advancement in cancer therapy.

Career Highlights

David Sai-Ho Chu is a key player at Avidity Biosciences, Inc., where he spearheads research and development initiatives. His extensive experience and dedication to innovation have positioned him as a valuable member of the biopharmaceutical community, allowing him to contribute significantly to advancements in therapeutic solutions.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Venkata Ramana Doppalapudi and Michael Caramian Cochran. These collaborations emphasize the importance of teamwork in driving innovation and the advancement of scientific research within the field of biotechnology.

Conclusion

David Sai-Ho Chu's pioneering work in biotechnology exemplifies the impact of innovation in improving healthcare outcomes. His contributions through numerous patents and collaboration with distinguished professionals highlight his vital role in advancing cancer treatment and the overall progress of biopharmaceutical technologies. With his continued efforts, David is poised to make further breakthroughs in the field, reinforcing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…